Fundraising FoxUrania Therapeutics
1 known investors
Find your way into Urania Therapeutics
Sign up to see every warm intro you have to Urania Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Urania Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Urania Therapeutics develops treatments for genetic diseases and cancers caused by nonsense mutations, targeting monogenic diseases in which a single gene defect impairs production of a functional protein. It focuses on rare diseases that collectively affect a large patient population but currently lack curative therapies.
Investors · 1
Frequently asked questions
- What does Urania Therapeutics do?
- Urania Therapeutics develops treatments for genetic diseases and cancers caused by nonsense mutations, targeting monogenic diseases in which a single gene defect impairs production of a functional protein. It focuses on rare diseases that collectively affect a large patient population but currently lack curative therapies.
- Who are Urania Therapeutics's investors?
- Urania Therapeutics's investors include AdBio partners.